logo
logo

OtoNexus Medical Technologies Receives 4th Consecutive Funding Round from Keiretsu Capital

OtoNexus Medical Technologies Receives 4th Consecutive Funding Round from Keiretsu Capital

07/09/20, 2:26 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgseattle
OtoNexus Medical Technologies Inc., announced today that Keiretsu Capital has invested in OtoNexus for the fourth time. Keiretsu Capital and Keiretsu Forum members are leading investors in OtoNexus with a total of $13 million in funding since the company's inception. The new investment round enables OtoNexus to finalize product development and testing for market introduction. 

Company Info

Company
Keiretsu Capital, Llc
Location
seattle, washington, united states
Additional Info
Keiretsu Capital, LLC is an affiliate of Keiretsu Forum, the world's leading angel investor network with over 3,000 investors in over 50 chapters on 3 continents. Keiretsu Forum has invested more than $750 million into more than 1,000 companies since inception. Keiretsu Capital administers funds on behalf of its Limited Partners - the Co-Investment & Opportunities Fund creates a diversified portfolio of technology start-ups backed by top tier angel groups and pursues the high upside value potential in these dynamic investment opportunities while promoting the sharing of risk inherent in any early stage venture.  The firm is based in Seattle and San Francisco and its principals are veteran Silicon Valley and technology investors Randy Williams, Matthew C. Le Merle and Nathan McDonald.